Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MAGG | 20.37 | 0.06 | +0.30% |
| Madison Aggregate Bond ETF | |||
| BUFF | 44.19 | 0.10 | +0.23% |
| Innovator Laddered Allc Pwr Bfr ETF™ | |||
| UOCT | 34.62 | 0.07 | +0.21% |
| Innovator U.S. Equity Ultra Buf ETF™ Oct | |||
| SSPX | 26.72 | N/A | N/A |
| Janus Henderson US Sustainable Eq ETF | |||
| IWX | 81.98 | -0.20 | -0.24% |
| iShares Russell Top 200 Value ETF | |||
A.I.dvisor indicates that over the last year, ARGNF has been loosely correlated with ARGX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ARGNF jumps, then ARGX could also see price increases.
| Ticker / NAME | Correlation To ARGNF | 1D Price Change % | ||
|---|---|---|---|---|
| ARGNF | 100% | N/A | ||
| ARGX - ARGNF | 54% Loosely correlated | -4.19% | ||
| BLUE - ARGNF | 45% Loosely correlated | +7.58% | ||
| MNKD - ARGNF | 30% Poorly correlated | -1.59% | ||
| TNXP - ARGNF | 25% Poorly correlated | -2.38% | ||
| ROIV - ARGNF | 24% Poorly correlated | -2.38% | ||
More | ||||